Autism and Cord Blood Stem Cells: FDA Gives Green Lite for Groundbreaking Clinical Trial
August 21, 2012
MultiVu / Powered by NewsLook.com
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world's largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child's own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
FORA.tv (Mar. 10, 2013) The Hidden Universality of Food Allergy
Gluten Free Society - Humble Civic Center
Dr. Russell M. Jaffe is Lab Director of ELISA/ACT Biotechnologies LLC and Fellow of the Health Studies Collegium. ... watch video
Reuters - Innovations Video Online (Feb. 4, 2014) Researchers at the Mayo Clinic are preparing to test their theory that stem cells grow faster in microgravity. With a grant from an organization that promotes research aboard the International Space ... watch video
Reuters (Oct. 31, 2013) Researchers in the US are developing a medical implant that can communicate with cells and organs deep inside the human body using lite. The research represents a significant achievement in the ... watch video
Reuters (Apr. 9, 2013) Doctors at Emory University in the US are testing a new stem cell therapy for people with severe arthritis. They hope that by harvesting stem cells from a patient, the potent cells will regenerate ... watch video
Newsy (May 15, 2014) The mice were given human stem cells to test stem cell rejection. But instead of rejecting the human cells, the mice began to show positive reactions.
Video provided by ... watch video
Reuters (Dec. 27, 2012) Chinese scientists from the Guangzhou Institutes of Biomedicine and Health have converted cells found in urine into pluripotent stem cells that can be used to create neurons and brain cells. The ... watch video
Reuters (Dec. 22, 2013) Scientists in New York have successfully turned human stem cells into functional lung and airway cells for the first time. It's a breakthrough the researchers at Columbia University believe could ... watch video
Newsy (Oct. 25, 2014) A Harvard University Research Team created genetically engineered stem cells that are able to kill cancer cells, while leaving other cells unharmed.
Video provided by ... watch video
Aug. 28, 2015 If you think that performing CPR on a person whose heart has stopped is a surefire way to save their life, you may be watching too much TV. The truth is more depressing than fiction, according to a ... read more
Aug. 28, 2015 Tumors are notoriously difficult to study in their natural habitat -- body tissues -- but a new synthetic tissue environment may give cancer researchers the next-best look at tumor growth and ... read more
Aug. 28, 2015 New research examines the experiences of California residents who have been prescribed medical marijuana and the stigma they experience from public opinion. The findings indicate that the stigma of ... read more
Aug. 28, 2015 A new international study shows that 5,000 fetuses in Europe annually are affected by spina bifida and other severe defects on the central nervous system. Seventy percent of these pregnancies are ... read more
Aug. 28, 2015 Researchers have unraveled a role for tumor suppressor genes in restricting the growth of neighboring cell populations. The study might have implications for understanding ... read more
Aug. 11, 2014 A clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries has been launched in the United States. Related goals of the clinical ... read more
Dec. 9, 2013 Donated umbilical cord blood contains stem cells that can save the lives of leukemia and lymphoma patients. A multi-center study has found that growing cord blood stem cells in a laboratory before ... read more
Dec. 12, 2011 A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases, a phase I ... read more